Figure 5. Effect of p53 mutation status on survival. Actuarial survival of patients with p53 mutations is compared with that of patients without p53 mutations. Patients with subcardia tumors and patients who died of postoperative complications are excluded. Patients with mutant tumors had significantly worse survival than patients with wild-type tumors. Censored values are denoted by a tick.